02:20 AM EDT, 10/27/2026 (MT Newswires) -- Novartis (NOVN.SW) logged $1.20 billion in net income attributable to shareholders for the third quarter, compared with $3.93 billion a year ago. EPS moved to $0.63 from $2.02 year over year, a Tuesday filing showed. For the three months ended Sept. 30, net sales to third parties were $14.52 billion versus $13.91 billion previously, the Swiss pharmaceutical giant added. Looking ahead, the group expects low-single-digit year-over-year growth in net sales for full-year 2026.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.